Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study

Journal Article Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study Get access C.P. Thakur, C.P. Thakur 1Kalaazar Research Centre, Patna, Bihar, India Search for other works by this author on: Oxford Academic PubMed Google Scholar T.P. Kanyok, T.P. Kanyok ∗ 2UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, World Health Organization, Geneva, Switzerland ∗Address for correspondence: Dr T. P. Kanyok, Manager, Product Development, UNDP/World Bank/WHO TDR, World Health Organization, 20 Avenue Appia, CH-1211, Geneva 27, Switzerland; fax +41 22 7913111. Search for other works by this author on: Oxford Academic PubMed Google Scholar A.K. Pandey, A.K. Pandey 1Kalaazar Research Centre, Patna, Bihar, India Search for other works by this author on: Oxford Academic PubMed Google Scholar G.P. Sinha, G.P. Sinha 1Kalaazar Research Centre, Patna, Bihar, India Search for other works by this author on: Oxford Academic PubMed Google Scholar C. Messick, C. Messick 2UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, World Health Organization, Geneva, Switzerland Search for other works by this author on: Oxford Academic PubMed Google Scholar P. Olliaro P. Olliaro 2UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, World Health Organization, Geneva, Switzerland Search for other works by this author on: Oxford Academic PubMed Google Scholar Transactions of The Royal Society of Tropical Medicine and Hygiene, Volume 94, Issue 4, July-August 2000, Pages 432–433, https://doi.org/10.1016/S0035-9203(00)90131-7 Published: 01 August 2000 Article history Received: 08 September 1999 Revision received: 16 December 1999 Accepted: 06 January 2000 Published: 01 August 2000